• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例在接受无缝合主动脉生物瓣膜置换术后进行具有挑战性的经皮冠状动脉介入治疗的病例。

A case of challenging percutaneous coronary intervention following surgical aortic valve replacement with a sutureless aortic bioprosthesis.

作者信息

Azumi Yuta, Nakama Tatsuya, Obunai Kotaro, Watanabe Hiroyuki

机构信息

Department of Cardiology, Tokyo Bay Medical Center, Urayasu, Japan.

出版信息

J Cardiol Cases. 2020 Jul 30;22(4):198-201. doi: 10.1016/j.jccase.2020.06.018. eCollection 2020 Oct.

DOI:10.1016/j.jccase.2020.06.018
PMID:33014205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7520531/
Abstract

A 71-year-old man with symptomatic severe aortic valve stenosis and stenosis of the proximal right coronary artery (RCA) underwent aortic valve replacement with Perceval (LivaNova, London, UK), a sutureless aortic bioprosthesis with a self-expanding open-cell designed nitinol frame (SL-AVR). Seven weeks after the SL-AVR, percutaneous coronary intervention (PCI) to the RCA was required. However, engagement of the guiding catheter (GC) was challenging because the RCA ostium was jailed by the strut of the Perceval. Therefore, the "Mother, Child, and Grandchild Technique" was used. A 4-Fr diagnostic catheter (DC) was partially engaged, and a support type 0.014-inch guidewire (GW) was inserted into the distal RCA. The DC was replaced by a 6-Fr GC. To fill the gap between the 0.014-inch GW and 6-Fr GC, a 5-Fr tapered inner sheath (IS, tip size was 3.0-Fr, used as Child catheter) was inserted into the 6-Fr GC (Mother catheter), and a 2.6-Fr microcatheter (Grandchild catheter) was inserted into the 5-Fr IS. Therefore, the gap between the 0.014-inch GW and 6-Fr GW was obliterated. Finally, we successfully inserted the PCI system and engaged the GC. RCA stenosis was treated using the conventional PCI technique. Herein, we report a case of successful PCI subsequent to SL-AVR. < The technical feasibility of percutaneous coronary intervention (PCI) following aortic valve replacement with a sutureless aortic bioprosthesis with a self-expanding open-cell designed nitinol frame (SL-AVR) remains unclear. In this report, we describe a case of challenging PCI following SL-AVR.>.

摘要

一名71岁男性,患有症状性严重主动脉瓣狭窄及右冠状动脉(RCA)近端狭窄,接受了使用Perceval(英国伦敦LivaNova公司生产)的主动脉瓣置换术,这是一种带有自膨胀开孔设计镍钛诺框架的无缝合主动脉生物假体(SL-AVR)。SL-AVR术后7周,需要对RCA进行经皮冠状动脉介入治疗(PCI)。然而,由于RCA开口被Perceval的支柱卡住,引导导管(GC)的置入具有挑战性。因此,采用了“祖孙三代技术”。将一根4F诊断导管(DC)部分置入,然后将一根支撑型0.014英寸导丝(GW)插入RCA远端。DC被一根6F GC取代。为了填补0.014英寸GW和6F GC之间的间隙,将一根5F锥形内鞘(IS,尖端尺寸为3.0F,用作子导管)插入6F GC(母导管),并将一根2.6F微导管(孙导管)插入5F IS。这样,0.014英寸GW和6F GW之间的间隙就被消除了。最后,我们成功插入了PCI系统并置入了GC。采用传统PCI技术治疗RCA狭窄。在此,我们报告一例SL-AVR术后成功进行PCI的病例。<使用带有自膨胀开孔设计镍钛诺框架的无缝合主动脉生物假体(SL-AVR)进行主动脉瓣置换术后经皮冠状动脉介入治疗(PCI)的技术可行性仍不明确。在本报告中,我们描述了一例SL-AVR术后具有挑战性的PCI病例。>

相似文献

1
A case of challenging percutaneous coronary intervention following surgical aortic valve replacement with a sutureless aortic bioprosthesis.一例在接受无缝合主动脉生物瓣膜置换术后进行具有挑战性的经皮冠状动脉介入治疗的病例。
J Cardiol Cases. 2020 Jul 30;22(4):198-201. doi: 10.1016/j.jccase.2020.06.018. eCollection 2020 Oct.
2
3
Sutureless versus Stented Bioprostheses for Aortic Valve Replacement: The Randomized PERSIST-AVR Study Design.主动脉瓣置换术的无缝合与带支架生物瓣膜:随机PERSIST-AVR研究设计
Thorac Cardiovasc Surg. 2020 Mar;68(2):114-123. doi: 10.1055/s-0038-1675847. Epub 2018 Nov 29.
4
Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.使用美敦力™自膨胀生物瓣膜进行经导管主动脉瓣置换术后冠状动脉造影和经皮冠状动脉介入治疗的可行性
Catheter Cardiovasc Interv. 2018 Jun;91(7):1339-1344. doi: 10.1002/ccd.27346. Epub 2017 Oct 8.
5
Letter to the Editor: Thrombocytopenia After Sutureless Aortic Valve Implantation: Does It Really Matter?致编辑的信:无缝合主动脉瓣植入术后血小板减少症:真的重要吗?
J Heart Valve Dis. 2017 Jul;26(4):492.
6
Percutaneous Coronary Intervention following Placement of Sutureless Aortic Bioprostheses.无缝合主动脉生物假体植入后的经皮冠状动脉介入治疗
Innovations (Phila). 2019 Apr;14(2):177-182. doi: 10.1177/1556984519836841. Epub 2019 Mar 18.
7
Aortic valve replacement in patients with protruding coronary artery stents.冠状动脉支架突出患者的主动脉瓣置换术。
J Cardiol Cases. 2014 Aug 22;10(6):213-215. doi: 10.1016/j.jccase.2014.07.013. eCollection 2014 Dec.
8
Aortic Valve Replacement with a Conventional Stented Bioprosthesis versus Sutureless Bioprosthesis: a Study of 763 Patients.传统带支架生物瓣膜与无缝合生物瓣膜置换主动脉瓣:763例患者的研究
Braz J Cardiovasc Surg. 2018 Mar-Apr;33(2):122-128. doi: 10.21470/1678-9741-2017-0088.
9
Direct and adjusted indirect comparisons of perioperative mortality after sutureless or rapid-deployment aortic valve replacement versus transcatheter aortic valve implantation.无缝合或快速部署主动脉瓣置换术与经导管主动脉瓣植入术后围手术期死亡率的直接和校正间接比较。
Int J Cardiol. 2017 Feb 1;228:327-334. doi: 10.1016/j.ijcard.2016.11.253. Epub 2016 Nov 12.
10
Left Coronary Ostial Obstruction by a Dislocated Sutureless Aortic Valve Prosthesis: Redo Aortic Valve Replacement with Hybrid Coronary Revascularization: A Case Report.脱位于冠状动脉开口处的无缝合主动脉瓣膜假体导致左冠状动脉开口阻塞:采用杂交冠状动脉血运重建术进行再次主动脉瓣置换术:病例报告
J Chest Surg. 2023 Sep 5;56(5):359-361. doi: 10.5090/jcs.22.146. Epub 2023 Mar 8.

引用本文的文献

1
Feasibility of guiding catheter exchange using extension wire in percutaneous coronary intervention after transcatheter aortic valve replacement.经导管主动脉瓣置换术后经皮冠状动脉介入治疗中使用延长导丝进行引导导管交换的可行性。
Cardiovasc Interv Ther. 2025 Jun 24. doi: 10.1007/s12928-025-01159-w.

本文引用的文献

1
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.经导管主动脉瓣置换术或外科主动脉瓣置换术的 5 年结果。
N Engl J Med. 2020 Jan 29;382(9):799-809. doi: 10.1056/NEJMoa1910555. Print 2020 Feb 27.
2
Percutaneous Coronary Intervention following Placement of Sutureless Aortic Bioprostheses.无缝合主动脉生物假体植入后的经皮冠状动脉介入治疗
Innovations (Phila). 2019 Apr;14(2):177-182. doi: 10.1177/1556984519836841. Epub 2019 Mar 18.
3
Prospective US investigational device exemption trial of a sutureless aortic bioprosthesis: One-year outcomes.前瞻性美国研究性器械豁免试验:一种无缝线主动脉生物瓣:一年结果。
J Thorac Cardiovasc Surg. 2019 May;157(5):1773-1782.e3. doi: 10.1016/j.jtcvs.2018.08.121. Epub 2018 Oct 23.
4
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When?经导管主动脉瓣植入术候选患者的冠状动脉血运重建:为何、何人、何时?
Interv Cardiol. 2018 May;13(2):69-76. doi: 10.15420/icr.2018:2:2.
5
Coronary Angiography and Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后的冠状动脉造影和经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Mar 27;71(12):1360-1378. doi: 10.1016/j.jacc.2018.01.057.